Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools

التفاصيل البيبلوغرافية
العنوان: Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools
المؤلفون: Downes, Michelle R., Liu, Kristen N., Yu, Yanhong, Lajkosz, Katherine, Kroon, Lisa J., Hollemans, Eva, Fleshner, Neil, Finelli, Antonio, van Leenders, Geert J.L.H., Iczkowski, Kenneth A., van der Kwast, Theodorus H.
المصدر: Clinical Genitourinary Cancer; February 2024, Vol. 22 Issue: 1 p47-55, 9p
مستخلص: Pretreatment stratification tools can help in clinical decision making in prostate cancer. To date, none incorporates well-established routinely reported adverse prognostic pathologic features such as intraductal carcinoma of prostate (IDC) or cribriform pattern 4 (CC).
قاعدة البيانات: Supplemental Index
الوصف
تدمد:15587673
DOI:10.1016/j.clgc.2023.07.013